Contrasting Medical Properties Trust (MPT) and The Competition

Medical Properties Trust (NYSE:MPT) is one of 88 publicly-traded companies in the “Real Estate Investment Trusts” industry, but how does it compare to its rivals? We will compare Medical Properties Trust to related businesses based on the strength of its risk, dividends, earnings, institutional ownership, profitability, valuation and analyst recommendations.

Earnings & Valuation

This table compares Medical Properties Trust and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Medical Properties Trust	$972.02 million	-$277.05 million	-10.43
Medical Properties Trust Competitors	$473.64 million	$15.54 million	27.02

Medical Properties Trust has higher revenue, but lower earnings than its rivals. Medical Properties Trust is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Medical Properties Trust and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medical Properties Trust	-28.50%	-5.87%	-1.85%
Medical Properties Trust Competitors	-36.03%	-19.16%	-0.33%

Analyst Ratings

This is a breakdown of current recommendations for Medical Properties Trust and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Properties Trust	1	0	0	0	1.00
Medical Properties Trust Competitors	2345	4032	2363	20	2.01

As a group, “Real Estate Investment Trusts” companies have a potential upside of 27.14%. Given Medical Properties Trust’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Medical Properties Trust has less favorable growth aspects than its rivals.

Volatility & Risk

Medical Properties Trust has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Medical Properties Trust’s rivals have a beta of 1.16, indicating that their average stock price is 16% more volatile than the S&P 500.

Institutional & Insider Ownership

71.8% of Medical Properties Trust shares are owned by institutional investors. Comparatively, 63.6% of shares of all “Real Estate Investment Trusts” companies are owned by institutional investors. 1.3% of Medical Properties Trust shares are owned by company insiders. Comparatively, 8.0% of shares of all “Real Estate Investment Trusts” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Dividends

Medical Properties Trust pays an annual dividend of $0.36 per share and has a dividend yield of 7.5%. Medical Properties Trust pays out -78.3% of its earnings in the form of a dividend. As a group, “Real Estate Investment Trusts” companies pay a dividend yield of 3.8% and pay out 105.0% of their earnings in the form of a dividend. Medical Properties Trust is clearly a better dividend stock than its rivals, given its higher yield and lower payout ratio.

Summary

Medical Properties Trust rivals beat Medical Properties Trust on 8 of the 15 factors compared.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.